.
Scientists are hailing a chemotherapy drug found to significantly increase the survival chances of child leukaemia patients whose cancer has returned.
A Cancer Research UK study found giving mitoxantrone to children whose acute lymphoblastic leukaemia returned led to a 69% survival rate after three years.
The standard treatment offers a 45% survival rate, The Lancet study says.
To read the full article on the BBC website click HERE.
No comments:
Post a Comment